Robert A Kaiser

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 3

Top Topics

Polycyclic Aromatic Hydrocarbons

Top Venues

Expert opinion on orphan drugs

Journal of inherited metabolic disease

Children's Hospitals and Clinics of Minnesota

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Children's Hospitals and Clinics of Minnesota

United States

Principal :: Experimental Pharm/Tox

Publications

Robert A Kaiser, Daniel F Carlson, Kari L Allen, Dennis A Webster, Caitlin J VanLith, Clara T Nicolas, Lori G Hillin, Yue Yu, Catherine W Kaiser, William R Wahoff, Raymond D Hickey, Adrienne L Watson, Shelley R Winn, Beat Thöny, Douglas R Kern, Cary O Harding, Joseph B Lillegard
Development of a porcine model of phenylketonuria with a humanized R408W mutation for gene editing. PloS one 16 (1) (2021)
Robert A Kaiser, Nicholas D Weber, Laia Trigueros-Motos, Kari L Allen, Michael Martinez, William Cao, Caitlin J VanLith, Lori G Hillin, Anne Douar, Gloria Gonzalez Aseguinolaza, Rafael Aldabe, Joseph B Lillegard
Use of an adeno-associated virus serotype Anc80 to provide durable cure of phenylketonuria in a mouse model. Journal of inherited metabolic disease 44 (6) (2021)
Whitney S Thompson, Gourish Mondal, Caitlin J Vanlith, Robert A Kaiser, Joseph B Lillegard
The future of gene-targeted therapy for hereditary tyrosinemia type 1 as a lead indication among the inborn errors of metabolism. Expert opinion on orphan drugs 8 (7) (2020)